Sickle Cell Disease Update: New Treatments and Challenging Nutritional Interventions

被引:9
|
作者
Bell, Victoria [1 ]
Varzakas, Theodoros [2 ]
Psaltopoulou, Theodora [3 ]
Fernandes, Tito [4 ,5 ]
机构
[1] Univ Coimbra, Fac Pharm, Polo Ciencias Saude, P-3000548 Coimbra, Portugal
[2] Univ Peloponnese, Dept Food Sci & Technol, Kalamata 24100, Greece
[3] Natl & Kapodistrian Univ Athens, Med Sch, Athens 11527, Greece
[4] Univ Lisbon, Fac Vet Med, CIISA, P-1649004 Lisbon, Portugal
[5] Lurio Univ, Nampula 3100, Mozambique
关键词
sickle cell; hemoglobin; anemia; microbiota; nutrition; vaso-occlusive crisis; HEMATOLOGY; 2020; GUIDELINES; AMERICAN SOCIETY; MOUSE MODELS; EDIBLE MUSHROOMS; HOST GENETICS; ANEMIA; CHILDREN; MICROBIOTA; SUPPLEMENTATION; GENOME;
D O I
10.3390/nu16020258
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Sickle cell disease (SCD), a distinctive and often overlooked illness in the 21st century, is a congenital blood disorder characterized by considerable phenotypic diversity. It comprises a group of disorders, with sickle cell anemia (SCA) being the most prevalent and serious genotype. Although there have been some systematic reviews of global data, worldwide statistics regarding SCD prevalence, morbidity, and mortality remain scarce. In developed countries with a lower number of sickle cell patients, cutting-edge technologies have led to the development of new treatments. However, in developing settings where sickle cell disease (SCD) is more prevalent, medical management, rather than a cure, still relies on the use of hydroxyurea, blood transfusions, and analgesics. This is a disease that affects red blood cells, consequently affecting most organs in diverse manners. We discuss its etiology and the advent of new technologies, but the aim of this study is to understand the various types of nutrition-related studies involving individuals suffering from SCD, particularly in Africa. The interplay of the environment, food, gut microbiota, along with their respective genomes collectively known as the gut microbiome, and host metabolism is responsible for mediating host metabolic phenotypes and modulating gut microbiota. In addition, it serves the purpose of providing essential nutrients. Moreover, it engages in direct interactions with host homeostasis and the immune system, as well as indirect interactions via metabolites. Nutrition interventions and nutritional care are mechanisms for addressing increased nutrient expenditures and are important aspects of supportive management for patients with SCD. Underprivileged areas in Sub-Saharan Africa should be accompanied by efforts to define and promote of the nutritional aspects of SCD. Their importance is key to maintaining well-being and quality of life, especially because new technologies and products remain limited, while the use of native medicinal plant resources is acknowledged.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] NEW TREATMENTS FOR SICKLE CELL DISEASE
    Wang, W.
    ACTA PAEDIATRICA, 2010, 99 : 22 - 22
  • [2] New Treatments for Sickle Cell Disease
    Reardon, Sara
    SCIENTIFIC AMERICAN, 2024, 331 (03)
  • [3] New treatments of sickle cell disease
    Embury, SH
    WESTERN JOURNAL OF MEDICINE, 1996, 164 (05): : 444 - 444
  • [4] Sickle cell disease - New treatments, new questions
    Cohen, AR
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01): : 42 - 44
  • [5] Update on sickle cell disease
    Hay, Deborah
    Atoyebi, Wale
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2016, 77 (04) : C55 - C59
  • [6] An update on sickle cell disease
    Adams, RJ
    NEUROLOGIST, 2000, 6 (01) : 12 - 17
  • [7] Sickle cell disease: an update
    O'Brien, Emma Conway
    Ali, Sahla
    Chevassut, Timothy
    CLINICAL MEDICINE, 2022, 22 (03) : 218 - 220
  • [8] Advances in Sickle Cell Disease Treatments
    Pavan, Aline Renata
    Dos Santos, Jean Leandro
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (10) : 2008 - 2032
  • [9] Applicability of criteria for empirically validated treatments to family interventions for pediatric sickle cell disease
    Collins, MH
    Loundy, MR
    Brown, FL
    Hollins, LD
    Aldridge, Y
    Eckman, J
    Kaslow, NJ
    JOURNAL OF DEVELOPMENTAL AND PHYSICAL DISABILITIES, 1997, 9 (04) : 293 - 309
  • [10] Applicability of Criteria for Empirically Validated Treatments to Family Interventions for Pediatric Sickle Cell Disease
    Marietta H. Collins
    Monica R. Loundy
    Fontina L. Brown
    Leslie D. Hollins
    Yvonne Aldridge
    James Eckman
    Nadine J. Kaslow
    Journal of Developmental and Physical Disabilities, 1997, 9 : 293 - 309